


Healthcare News Roundup: Venture Capital
HSMN NewsFeed - 1 Dec 2014
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
HSMN NewsFeed - 29 Oct 2014
Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug
Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug
HSMN NewsFeed - 28 Oct 2014
Advent Life Sciences Raises £145.5M (USD 235M) for its Second Life Sciences Venture Capital Fund
Advent Life Sciences Raises £145.5M (USD 235M) for its Second Life Sciences Venture Capital Fund
